Mariam Nawas to Graft vs Host Disease
This is a "connection" page, showing publications Mariam Nawas has written about Graft vs Host Disease.
Connection Strength
2.402
-
Higher graft cell dose does not influence development of acute or chronic GVHD in haploidentical transplantation using PTCy. Blood Adv. 2023 08 22; 7(16):4475-4478.
Score: 0.784
-
Dynamic EASIX scores closely predict nonrelapse mortality after allogeneic hematopoietic cell transplantation. Blood Adv. 2022 11 22; 6(22):5898-5907.
Score: 0.744
-
CD34+ -selected hematopoietic stem cell transplant conditioned with a myeloablative regimen in patients with advanced myelofibrosis. Bone Marrow Transplant. 2022 07; 57(7):1101-1107.
Score: 0.715
-
The clinical implications of clonal hematopoiesis in hematopoietic cell transplantation. Blood Rev. 2021 03; 46:100744.
Score: 0.159